| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/06/2009 | CA2216546C 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
| 01/06/2009 | CA2120319C Pharmaceutical for the treatment of skin disorders |
| 01/02/2009 | DE102007030103A1 Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel Use of a synergistic composition as a therapeutic or cosmetic agent |
| 01/01/2009 | US20090007280 Ange gene in atopy |
| 01/01/2009 | US20090005439 Mixture of organic peroxide such as benzoyl peroxide and antioxidant such as butylated hydroxyltoluene; shelf life, storage stability; skin disorders, acne agents; cosmetics |
| 01/01/2009 | US20090005437 Alpha-Ketoglutarates and Their Use as Therapeutic Agents |
| 01/01/2009 | US20090005420 Inhibitors of Matrix Metallaproteinases |
| 01/01/2009 | US20090005410 N-(4-Chloro-2-[1,2,3]triazolo[4,5-b]pyridin-1-yl-phenyl)-4-(1-hydroxy-1-methyl-ethyl)-benzene-sulfonamide sodium salt, used as chemokine receptors antagonists, useful for treating inflammation |
| 01/01/2009 | US20090005405 Compositions and methods for treating and preventing dermatoses |
| 01/01/2009 | US20090005390 Novel quinuclidine derivatives and their use |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005344 Blocking inflammatory cytokines; tumor necrosis factor; phosphodieaterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders; chronic obstructive pulmonary disorders |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005330 Methods and Compositions to Inhibit P2x7 Receptor Expression |
| 01/01/2009 | US20090005317 Methods for treating a corneal disorder and promoting skin wound healing |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090005303 Proteases from carica having mitogenic activity and their methods of use |
| 01/01/2009 | US20090004301 Method of treating dyshidrosis(pompholyx) and related dry skin disorders |
| 01/01/2009 | US20090004252 Skin Coating Composition and Uses Thereof |
| 01/01/2009 | US20090004238 Implantation of encapsulated biological materials for treating diseases |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004232 Bioactive pharmaceutical/cosmetic compositions and mixed solubilization process for the formulation thereof |
| 01/01/2009 | US20090004193 Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| 01/01/2009 | US20090004169 Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof |
| 01/01/2009 | US20090004161 Methods for treating pustular conditions of the skin |
| 01/01/2009 | US20090004160 Mass Producing Method of Growth Factor Using Adipose Derived Adult Stem Cells |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 12/31/2008 | WO2009002913A1 Use of creatine compounds to treat dermatitis |
| 12/31/2008 | WO2009002811A2 Therapeutic platelet compositions and methods |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY |
| 12/31/2008 | WO2009001551A1 Regulator of activity of bone-forming protein |
| 12/31/2008 | WO2009001260A2 Cosmetic use of apolipoprotein d type proteins |
| 12/31/2008 | WO2009001209A1 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| 12/31/2008 | WO2009000935A1 Slimming composition |
| 12/31/2008 | WO2009000875A2 Lactobacillus helveticus bacterium composition for treatment of atopic dermatitis |
| 12/31/2008 | WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | WO2008023278A8 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 12/31/2008 | WO2008003978A3 Dioxo-alkanes and dioxo-alkenes |
| 12/31/2008 | EP2008663A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer |
| 12/31/2008 | EP2008660A1 Inhibitors of acetylcholinesterase for treating skin diseases |
| 12/31/2008 | EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides |
| 12/31/2008 | EP2007746A1 Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity |
| 12/31/2008 | EP2007431A2 Topical drug delivery |
| 12/31/2008 | EP2007408A2 Preventative treatment and remission of allergic diseases |
| 12/31/2008 | EP2007391A2 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor |
| 12/31/2008 | EP1912641A4 Methods and compositions containing natural folates for protecting against radiation damage |
| 12/31/2008 | EP1569724B1 Formulations containing melatonin, ginkgo biloba, and biotin |
| 12/31/2008 | EP1542974B1 5-[((2,3-difluorophenyl)methyl)thio]-7-{[(1S,2S)-2-hydroxy-1-(hydroxymethyl)propyl]amino}thiazolo[4,5-d]pyrimidin-2(3H)-one as CXCR2 antagonist |
| 12/31/2008 | EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 12/31/2008 | EP1324756B1 Fatty acid analogues for the treatment of proliferative skin disorders |
| 12/31/2008 | EP1309587B1 Cinnoline compounds |
| 12/31/2008 | EP1203239B1 Use of a polypeptide for detecting a pathological condition associated with multiple sclerosis |
| 12/31/2008 | CN101333258A Fusion polypeptide with antimicrobial and wound healing promoting function |
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/31/2008 | CN101332302A Formula for preparing anti-eczema and cutitis products and preparation method thereof |
| 12/31/2008 | CN101332286A Traditional Chinese medicine composition for treating skin disease and preparation method thereof |
| 12/31/2008 | CN101332283A Spray medicine for treating body odor |
| 12/31/2008 | CN101332278A Medicine for treating tinea manuum |
| 12/31/2008 | CN101332274A Compound grape-seed cream and preparation method thereof |
| 12/31/2008 | CN101332271A External medicine composition for treating burn and scald |
| 12/31/2008 | CN101332270A External traditional Chinese medicine for treating vitiligo |
| 12/31/2008 | CN101332265A External preparation for treating skin persistent ailment, e.g. tinea capitis, tinea corporis |
| 12/31/2008 | CN101332261A External medicine for treating furunculosis |
| 12/31/2008 | CN101332252A Beriberi treating ointment |
| 12/31/2008 | CN101332251A Decoction for treating wind-heat type drug dermatitis |
| 12/31/2008 | CN101332249A Liquor for treating scalding and burning |
| 12/31/2008 | CN101332244A Oral traditional Chinese medicine for treating diffused neurodermatitis |
| 12/31/2008 | CN101332239A Externally used drug for treating tinea |
| 12/31/2008 | CN101332224A Decoction for treating miliaria |
| 12/31/2008 | CN101332202A Tobramycin lotion and preparation method thereof |
| 12/31/2008 | CN101332183A O/W emulsification preparation containing steride |
| 12/31/2008 | CN101331943A Production method of freeze-dry instant health wood-frog oil |
| 12/31/2008 | CN101331906A Drink containing Congrong and coffee |
| 12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
| 12/31/2008 | CN100447141C Hetero-bicyclic crf antagonists |
| 12/31/2008 | CN100446814C Compound econazole nitrate film forming gel composition and its use |
| 12/31/2008 | CN100446801C Ointment for eliminating macula and its preparation method |
| 12/31/2008 | CN100446788C Externally applied Chinese medicine preparation for treating eczema, tinea of feet and hands, vaginitis, etc and its preparing process |
| 12/31/2008 | CN100446776C Superoxide anion decomposing agent |
| 12/31/2008 | CN100446773C Compound micro-cream for acne treatment and preparation method thereof |
| 12/31/2008 | CN100446760C Medicated chitin fiber for treating and preventing proliferation of mammary gland, prepn. method and application thereof |
| 12/31/2008 | CN100446754C Prepn process of skin icing snake fat ointment |
| 12/31/2008 | CA2692191A1 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| 12/31/2008 | CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/30/2008 | US7470704 Benzonaphthyridines |
| 12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis |
| 12/30/2008 | US7470681 Pyrimidine compounds |
| 12/30/2008 | US7470438 Inhibiting expression of metalloproteases, collagen degradation, and/or UV-induced skin degradation; collagenase inhibitors; wrinkle resistance |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 12/30/2008 | CA2368767C Protease resistant flint analogs |
| 12/30/2008 | CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |
| 12/30/2008 | CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 12/30/2008 | CA2288482C Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis, dermatitis and dermatosis |
| 12/30/2008 | CA2223720C Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 12/30/2008 | CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |